Femasys (FEMY) Other Non-Current Assets (2020 - 2026)
Femasys' (FEMY) quarterly Other Non-Current Assets came in at $924552.0 in Q1 2026, up 10.32% YoY from $838043.0 in Q1 2025, and down 1.67% on a QoQ basis from $940232.0 in Q4 2025.
Femasys (FEMY) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Other Non-Current Assets data on file, last reported at $924552.0 in Q1 2026.
- Quarterly Other Non-Current Assets rose 10.32% year-over-year to $924552.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $924552.0 (up 10.32% YoY) and the FY2025 annual result came in at $940232.0, down 1.55% from the prior year.
- Other Non-Current Assets retreated to $924552.0 in Q1 2026, from $940232.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.1 million in Q4 2023 to a low of $625418.0 in Q1 2022.
- A 5-year average of $878565.8 and a median of $920812.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 84.09% — and 2025, when it retreated 17.27%.
- Tracing FEMY's Other Non-Current Assets over 5 years: stood at $958177.0 in 2022, then rose by 13.4% to $1.1 million in 2023, then slipped by 12.11% to $954992.0 in 2024, then retreated by 1.55% to $940232.0 in 2025, then declined by 1.67% to $924552.0 in 2026.
- The last three Other Non-Current Assets figures came in at $924552.0 (Q1 2026), $940232.0 (Q4 2025), and $744803.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Femasys | 9.97 Mn | 8.53 Mn | 189,391.00 | 918,618.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 924,552.00 |
| Dec 31, 2025 | 940,232.00 |
| Sep 30, 2025 | 744,803.00 |
| Jun 30, 2025 | 829,204.00 |
| Mar 31, 2025 | 838,043.00 |
| Dec 31, 2024 | 954,992.00 |
| Sep 30, 2024 | 887,410.00 |
| Jun 30, 2024 | 957,078.00 |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 936,996.00 |
| Jun 30, 2023 | 865,588.00 |
| Mar 31, 2023 | 920,812.00 |
| Dec 31, 2022 | 958,177.00 |
| Sep 30, 2022 | 789,616.00 |
| Jun 30, 2022 | 663,083.00 |
| Mar 31, 2022 | 625,418.00 |
| Dec 31, 2021 | 655,418.00 |
| Sep 30, 2021 | 428,933.00 |
| Jun 30, 2021 | 488,961.00 |